Background: There are no guidelines for antithrombotic therapy on admission to hospice care. Antithrombotic therapy may offer some benefit in these patients, but is also associated with well-described risks.

Objective: We quantified the frequency and characteristics of patients prescribed antithrombotic therapy on discharge from acute care to hospice care.

Design: Retrospective cohort study.

Settings/Subjects: Adult (age>=21 years) patients discharged from acute care to hospice care between January 1, 2010 and June 30, 2014.

Measures: Our primary outcome of interest was receiving an outpatient prescription for antithrombotic therapy on discharge to hospice care.